35
Participants
Start Date
August 5, 2020
Primary Completion Date
May 10, 2021
Study Completion Date
May 10, 2021
interoperable Artificial Pancreas System (iAPS)
Use of the iAPS at home for 13 weeks, with weekly adaptation of insulin delivery settings occurring automatically in the iAPS.
Sensor-Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS)
Use of personal pump with study CGM \& glucometer at home for 13 weeks.
Icahn School of Medicine at Mount Sinai, New York
Mayo Clinic, Rochester
Sansum Diabetes Research Institute, Santa Barbara
Stanford University, Stanford
Joslin Diabetes Center, Boston
Collaborators (1)
Harvard University
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Jaeb Center for Health Research
OTHER
Sansum Diabetes Research Institute
OTHER